1/67
Comprehensive practice flashcards detailing cell cycle phases, checkpoints, mitotic segregation, cancer pathology and genetics, as well as meiotic gametogenesis, chromosomal inheritance, and aneuploidies.
Cell Cycle
The life cycle of a typical eukaryotic cell from its formation until its division, requiring on average 7 to 10 years to complete in the human body depending on the specific cell type.
Stem Cells
Undifferentiated cells with the potential to develop into any of more than 200 cell types, found as pluripotent cells in the embryo and as tissue-specific precursor cells in adult tissues such as bone marrow.
Cell Differentiation
The irreversible developmental process driven by biochemical signals through which a stem cell specializes to perform a specific function and expresses only the genes required for its assigned role.
Sonic Hedgehog (SHH)
A morphogenetic signaling protein identified in 1991 by Dr. Robert Riddle whose local concentration gradients instruct embryonic cells on their positional identity, critical for the development of the nervous system, eyes, and limbs.

Cyclopia
A severe congenital malformation caused by a non-functional mutated SHH gene, characterized by fused single-eye formation, failure of the forebrain to divide into two hemispheres, and the nose developing above the eye as a proboscis.
Interphase
The non-dividing growth and preparation phase accounting for more than 90% of a eukaryotic cell's life cycle, consisting sequentially of the G1, S, and G2 sub-phases.
G1 Phase
The initial growth phase of interphase directly following cell division, during which the cell enlarges its size, multiplies its organelles, and synthesizes cell-specific proteins prior to DNA replication.
G1 Checkpoint
The regulatory decision point near the end of the G1 phase where control proteins check for DNA errors, sufficient cell size, adequate nutrient and organelle reserves, and favorable surrounding conditions before irreversibly committing the cell to division.
G0 Phase
A non-dividing, metabolically active state entered by cells that exit the cell cycle at the G1 checkpoint (such as brain, heart, and eye cells) that have extremely long lifespans and cannot be replaced if damaged.
S Phase (Synthesis)
The interphase period during which nuclear DNA is replicated, converting each of the 46 single-filament chromosomes into two identical sister chromatids conjoined at the centromere.
Centromere
The constricted, specialized chromosomal region that tethers sister chromatids together and serves as the attachment site for spindle microtubules during cell division.
Sister Chromatids
The two identical duplicate copies of a single replicated chromosome joined together at a centromere, totaling 92 chromatids across the 46 chromosomes at the completion of S phase.
G2 Phase
The relatively brief interphase interval between DNA synthesis and mitosis, during which the cell grows further and produces the ATP and specialized proteins necessary for nuclear division.
G2 Checkpoint
The critical regulatory verification point at the end of the G2 phase where control proteins ensure DNA replication is free of damage and sufficient ATP and proteins are present before allowing mitotic entry.
Apoptosis
Programmed cell death initiated by unrepairable checkpoint damage or severe stress, wherein a cell fragments into apoptotic bodies to be engulfed and recycled by neighboring cells, eliminating approximately 0.5% (roughly 15 billion) of human cells daily.

Mitosis
The process of eukaryotic nuclear division that segregates replicated chromosomes so that each resulting daughter nucleus receives an identical diploid (2N) set of chromosomes.
Diploid (2N)
A cellular state characterized by having two homologous sets of chromosomes (23 pairs in humans, totaling 46 chromosomes), typical of all somatic body cells.

Centrioles
Paired cylindrical, barrel-shaped organelles that migrate to opposite cellular poles during division to organize and anchor the mitotic spindle microtubules.
Mitotic Spindle (Microtubules)
Dynamic protein fibers that polymerize outward from centrioles, attach to chromosome centromeres, and exert pulling forces to separate chromatids toward opposite cellular poles.
Prophase
The first phase of mitosis, characterized by maximal chromosome condensation, disintegration of the nuclear envelope, and the migration of centrioles toward opposite poles as spindle fibers begin to assemble.
Metaphase
The second mitotic phase in which centrioles settle at opposite poles, chromosomes align single-file across the cellular equator (metaphase plate), and microtubules attach to each chromatid's centromere.
Mitotic Checkpoint
The regulatory checkpoint operating during metaphase that monitors whether every chromatid is properly and securely tethered to spindle microtubules before allowing separation in anaphase.
Anaphase
The third mitotic stage wherein centromeric connections are broken and sister chromatids are pulled in opposite directions toward the centrioles, transforming each chromatid into an independent daughter chromosome.
Telophase
The final stage of mitosis during which separated chromosome groups arrive at opposite poles, chromosomes decondense, and two separate nuclear envelopes assemble around each chromosomal cluster.
Cytokinesis
The physical division of the parent cell's cytoplasm into two distinct daughter cells, distinct from mitosis, initiated during or immediately following telophase.
Contractile Ring
A ring of microfilament proteins that constricts inward beneath the flexible plasma membrane of an animal cell during cytokinesis to pinch the cell into two separate entities.

Cell Plate
The newly developing partition synthesized across the equator of a dividing plant cell that fuses with the plasma membrane to establish the middle lamella and new rigid cellulose cell walls.
Neoplasm
An abnormal cluster or mass of tissue generated by unregulated cellular growth and division originating from a single transformed cell, manifesting clinically as a tumor.
Benign Tumor
A non-cancerous neoplasm that maintains contact inhibition, remains localized within a specific tissue boundary, and does not invade surrounding structures or spread to distant sites.
Malignant Tumor
A cancerous neoplasm characterized by loss of contact inhibition, aggressive invasion into adjacent tissues, and the capacity to enter circulatory pathways to colonize distant organs.
Contact Inhibition
The natural regulatory mechanism exhibited by normal and benign cells that arrests mitotic division when cells come into physical contact with neighboring cells, a property lost in cancer cells.
Adenoma
A benign neoplasm originating in glandular epithelial tissue (such as the thyroid, prostate, colon, or salivary glands) that frequently appears as a polyp and carries potential for malignant transformation over time.
Lipoma
A benign tumor of adipose (fat) tissue occurring in approximately 2% of people that remains soft and localized and carries no association with future malignant cancer risk.
Nevus
A benign skin tumor composed of melanin-producing melanocytes (mole) that can become malignant melanoma if it displays asymmetry, irregular margins, uneven coloration, or an enlarged diameter exceeding a pencil eraser.

Papilloma
A benign epithelial growth (wart) of the skin or mucous membranes, commonly induced by Human Papillomavirus (HPV), which is non-cancerous but correlates with an increased risk of specific cancers.
Human Papillomavirus (HPV)
A common sexually transmitted virus associated with genital warts that causes virtually 100% of cervical cancers, 90% of anal cancers, 60% to 73% of throat cancers, and 40% to 50% of penile cancers.
Metastasis
The dissemination of malignant cancer cells from a primary tumor through blood or lymphatic vessels into distant body tissues to establish secondary tumors, defining Stage 4 cancer.

Lymphatic System
A specialized immune and vascular network of organs and thin-walled vessels that acts as the primary and most accessible conduit for metastatic cancer cells migrating throughout the body.
Proto-oncogenes
Normal, unmutated genes that encode essential checkpoint and regulatory proteins responsible for controlling normal cell growth and cell cycle progression.
Oncogenes
Mutated, cancer-promoting genes derived from proto-oncogenes that cause defective cell cycle regulation, rapid cell division, and impaired apoptosis.
p53 (TP53) Gene
The most common tumor suppressor gene mutated in over 50% of all cancers; its normal protein product acts at the G1 checkpoint to arrest cycling for DNA repair or trigger apoptosis.
Carcinogen
An environmental agent or mutagen—such as tobacco smoke (∼90% of lung cancers), radon (∼30% of lung cancers), asbestos, or ultraviolet radiation—that induces genetic mutations that transform proto-oncogenes into oncogenes.
BRCA1 and BRCA2
Tumor suppressor genes encoding DNA-repair enzymes whose inherited mutations elevate lifetime breast cancer risk to over 60% (compared to 13% baseline), ovarian cancer risk to 39% to 58% for BRCA2, and prostate cancer risk in men.

p Arm and q Arm
The two structural segments of a eukaryotic chromosome separated by an off-center centromere, designating the shorter segment as the p arm and the longer segment as the q arm.
Homologous Chromosomes
Pairs of matching maternal and paternal chromosomes possessing identical lengths, centromere locations, and gene loci that carry different versions (alleles) of the same genes.
Autosomes
The 22 non-sex chromosome pairs in human cells (numbered by physical size from chromosome 1 as longest down to chromosome 22 as shortest) that govern general physiological traits.
Sex Chromosomes
The 23rd pair of chromosomes (X and Y in humans) that govern primary sex determination and gonadal development; they are not fully homologous in males (XY) because the Y chromosome is significantly shorter.
ZW Sex-Determination System
The biological sex-determination system characteristic of birds and certain reptiles where genetic males possess two identical chromosomes (ZZ) and genetic females possess two distinct chromosomes (ZW).
Intersex
A biological condition occurring in approximately 2% of live human births where an individual is born with a reproductive or chromosomal configuration displaying combinations of both male and female anatomy.
Somatic Cells
Any non-reproductive diploid (2n) biological cells constituting the body of an organism (such as skin, liver, muscle, or brain cells) containing 46 chromosomes.
Gametes
Specialized reproductive cells—spermatozoa in males and ova in females—that contain a single haploid set of chromosomes (n=23) designed to fuse during sexual fertilization.
Zona Pellucida
A dense, gelatinous extracellular glycoprotein matrix enveloping an unfertilized ovum that hardens enzymatically upon the entry of the first successful sperm to prevent polyspermy.
Zygote
The initial diploid (2n=46) single cell of a new organism produced by the gametic fusion of a haploid sperm (23) and a haploid ovum (23), which subsequently undergoes mitotic embryogenesis.
Meiosis
A two-division germ-cell reduction process (Meiosis I and Meiosis II) that transforms diploid (2n) reproductive progenitor cells into four genetically diverse haploid (n) gametes.
Tetrad
A paired complex consisting of four chromatids formed when replicated homologous chromosomes align and physically bind together during prophase I of meiosis.
Synapsis
The pairing process in prophase I of meiosis where homologous chromosome pairs zipper together lengthwise along chiasmata to establish a tetrad.
Chiasma
The structural, microscopic X-shaped contact point where non-sister chromatids of homologous chromosomes overlap, cross over, and exchange genetic segments during synapsis.

Crossing-Over (Recombination)
The enzymatic exchange of genetic segments between non-sister homologous chromatids at chiasmata mediated by recombinases 2 to 4 times per homolog pair during prophase I, producing novel gene combinations.
Spermatogenesis
The continuous, life-long production of male gametes in the seminiferous tubules of the testes from puberty until death, converting spermatogonia into primary spermatocytes, spermatids, and mature spermatozoa.
Oogenesis
The female gametogenic process beginning in fetal development, arresting until puberty, and resuming cyclically to produce a single mature nutrient-rich ovum and three non-functional polar bodies per cycle.
Polar Bodies
Small haploid cellular byproducts generated during meiotic divisions of oogenesis that receive negligible cytoplasm and degenerate via apoptosis, allowing the primary ovum to conserve cellular resources.
Independent Assortment
The random maternal versus paternal orientation of homologous chromosome pairs along the metaphase plate in metaphase I, creating 223=8.4 million potential gametic chromosome combinations in humans.
Random Fertilization
The random union of any unique sperm with any unique ovum, each possessing 8.4 million chromosomal combinations, creating roughly 70 trillion possible zygotic chromosomal combinations (exclusive of crossing-over).

Nondisjunction
The pathological failure of homologous chromosome pairs to separate in meiosis I or sister chromatids to disjoin in meiosis II, generating aneuploid gametes with extra or missing chromosomes.
Aneuploidy
An abnormal chromosome complement (such as monosomy or trisomy) resulting from nondisjunction, present in 1 in 150 pregnancies and responsible for 50% to 60% of first-trimester miscarriages.
Karyotype
A visual laboratory analysis and micrograph depicting a mitotic cell's condensed chromosomes lined up in homologous pairs ordered from largest (chromosome 1) to smallest (chromosome 22), ending with the sex chromosomes.
Down Syndrome (Trisomy 21)
A survivable human aneuploidy resulting from three copies of chromosome 21, associated with intellectual disability, congenital heart defects, and maternal age-related incidence peaking at 29% of live Down syndrome births between maternal ages 35 and 39.
Klinefelter Syndrome (47,XXY)
A sex chromosome aneuploidy characterized by an XXY genotype in phenotypic males, resulting in improper male anatomical development and the emergence of female secondary sexual characteristics at puberty.